Charles A. Nicolette
Chief Executive Officer at CoImmune, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Edgardo Baracchini | M | 64 |
CoImmune, Inc.
CoImmune, Inc. Pharmaceuticals: MajorHealth Technology CoImmune, Inc. engages in manufacture and development of cell-based therapeutics. It offers warehouse management, processing suites, logistics, research labs, and qualification and validation. The company was founded in February 2019 and is headquartered in Durham, NC. | 3 years |
Gregory Tibbitts | M | 57 |
CoImmune, Inc.
CoImmune, Inc. Pharmaceuticals: MajorHealth Technology CoImmune, Inc. engages in manufacture and development of cell-based therapeutics. It offers warehouse management, processing suites, logistics, research labs, and qualification and validation. The company was founded in February 2019 and is headquartered in Durham, NC. | 3 years |
Michael Fekete | M | 59 |
CoImmune, Inc.
CoImmune, Inc. Pharmaceuticals: MajorHealth Technology CoImmune, Inc. engages in manufacture and development of cell-based therapeutics. It offers warehouse management, processing suites, logistics, research labs, and qualification and validation. The company was founded in February 2019 and is headquartered in Durham, NC. | 3 years |
Irina Y. Tcherepanova | M | - |
CoImmune, Inc.
CoImmune, Inc. Pharmaceuticals: MajorHealth Technology CoImmune, Inc. engages in manufacture and development of cell-based therapeutics. It offers warehouse management, processing suites, logistics, research labs, and qualification and validation. The company was founded in February 2019 and is headquartered in Durham, NC. | 5 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Lori R. Harrelson | F | 54 | - | |
Andrei Vladimirovich Petrov | M | 50 | 3 years | |
Philippe van Holle | M | 69 | 2 years | |
Alexey Vinogradov | M | 54 | 2 years | |
Robert Carey | M | 65 | 4 years | |
Sander J. van Deventer | M | 69 | 17 years | |
Clint G. Dederick | M | - | 4 years | |
Louis J. Arcudi | M | 63 |
Genzyme Molecular Oncology
Genzyme Molecular Oncology Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Molecular Oncology is a company that develops novel cancer therapeutics and diagnostics. The company is based in Cambridge, MA. The company was founded by Gail J. Maderis. | 5 years |
Richard D. Katz | M | 60 | 2 years | |
Monique Laliberte | F | - | - | |
Jean Lamarre | M | 70 | 2 years | |
Brian Underdown | M | 83 | 17 years | |
John N. Bonfiglio | M | 69 | 4 years | |
John D. Menditto | M | - | 2 years | |
David Gryska | M | 68 | 2 years | |
Joan C. Winterbottom | F | 67 | 2 years | |
Igor Krol | M | 51 | - | |
Douglas C. Plessinger | M | 55 | - | |
Irackly Mtibelishvily | M | - | 2 years | |
Matthew Foster | M | - | - | |
Michel Gréco | M | 80 | 8 years | |
Lothar H. Finke | M | - | 5 years | |
Gilbert W. Carnathan | M | - | - | |
Tamao Watanabe | M | - | - | |
Lee F. Allen | M | 72 | 1 years | |
Frederick M. Miesowicz | M | 75 | 13 years | |
Timothy Trost | M | 66 | 8 years | |
Richard G. Morrison | M | 87 | - | |
M. Douglas Winship | M | 75 | 1 years | |
Ralph Snyderman | M | 84 | 1 years | |
Shawn Leland | M | 40 | 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 35 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Charles A. Nicolette
- Personal Network